George Golumbeski
Vorsitzender bei SHATTUCK LABS, INC.
Vermögen: 642 755 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jeff Jonas | M | 71 | 11 Jahre | |
Steven Paul | M | 73 | 14 Jahre | |
Stephen Stout | M | 49 | 3 Jahre | |
Taylor Schreiber | M | 44 | 8 Jahre | |
David Hochman | M | 49 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 8 Jahre |
Geno Germano | M | 63 | 8 Jahre | |
Amy Schacterle | M | - | 9 Jahre | |
Carrie Brownstein | M | 54 | 7 Jahre | |
Conor Richardson | M | - | 5 Jahre | |
Marc Cluzel | M | 69 | 12 Jahre | |
Elizabeth Gray | M | - |
National Audubon Society, Inc.
National Audubon Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Audubon Society, Inc. conserves and restores natural ecosystems. The firm preserves species of birds, other animals, and their natural habitats. Its projects include saving habitat in the everglades, arctic wildlife refuge, long island sound, and mississippi river basin. The company was founded in 1905 by George Bird Grinnell and is headquartered in New York City, NY. | 3 Jahre |
Barry Greene | M | 60 | 4 Jahre | |
Helen Boudreau | F | 58 | 4 Jahre | |
David Goldstein | M | - |
Actio Biosciences, Inc.
Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Actio Biosciences, Inc. is an American precision medicine company that focuses on developing new therapeutics for rare and common diseases by targeting shared genetics. Actio Biosciences was founded in October 2021 and is based in an undisclosed location. The company applies its expertise in genetics, drug discovery, and data sciences to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward potent and precisely targeted therapeutics. The company is led by leaders in genetics and drug development and backed by top healthcare investors. | 3 Jahre |
Neil Gibson | M | 67 | 8 Jahre | |
Heinrich Schlieker | M | - | 9 Jahre | |
Ashwani Bahl | M | - |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | - |
Edward Ainscow | M | - |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | - |
Daniel Anderson | M | - |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | 7 Jahre |
Catherine Stehman-Breen | M | 61 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | 4 Jahre |
Krisja Vermeylen | F | 62 | 7 Jahre | |
Lori Hu | F | 38 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA.
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 9 Jahre |
Yuval Cohen | M | 49 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 Jahre |
Tatiana Novobrantseva | M | - |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | 7 Jahre |
Julia Neugebauer | M | - | 18 Jahre | |
Tyler Brous | M | 41 | 8 Jahre | |
Jessica Federer | F | - | 1 Jahre | |
Andrew Neill | M | 38 | 5 Jahre | |
George Fromm | M | 45 | 7 Jahre | |
Daniel Palmacci | M | - | 4 Jahre | |
Vic Myer | M | - |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | 4 Jahre |
Günter Wellnhofer | M | - | 30 Jahre | |
Joshua J. Ofman | M | 60 |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | 5 Jahre |
Michael Cola | M | 64 | 10 Jahre | |
Mark Foletta | M | 63 | 4 Jahre | |
Kimi Iguchi | F | 61 | 11 Jahre | |
Anne Cook | F | 62 | 9 Jahre | |
Lesley Russell | M | 63 | 8 Jahre | |
Jim Frates | M | 56 | 10 Jahre | |
Daniel Bradbury | M | 62 |
Keck Graduate Institute of Applied Life Sciences
| 18 Jahre |
Michael Lee | M | 45 | 4 Jahre | |
Robert Langer | M | 75 |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | 7 Jahre |
Paul Berns | M | 57 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 6 Jahre |
Luisa Ciccarelli | F | - | 3 Jahre | |
Kristine Peterson | F | 64 | 7 Jahre | |
Casi de Young | F | 53 |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | 11 Jahre |
Elizabeth Barrett | F | 62 | 5 Jahre | |
Timothy Pearson | M | 56 |
Carrick Therapeutics UK Ltd.
Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019.
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | 5 Jahre |
Michael Brosnan | M | 69 | 6 Jahre | |
Sandeep Bhadra | M | - |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 7 Jahre |
Bonnie Anderson | F | 66 |
Keck Graduate Institute of Applied Life Sciences
| - |
Johann DeBono | M | - |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | - |
Cecilia Fernandez | F | - |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | - |
Tim Demuth | M | 50 | 2 Jahre | |
Brendan Luu | M | 49 | 3 Jahre | |
Alice T. Kane | F | 76 |
Keck Graduate Institute of Applied Life Sciences
| - |
Barbara White | M | 73 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 Jahre |
Dennis Fenton | M | 72 |
Keck Graduate Institute of Applied Life Sciences
| - |
Kevin Bitterman | M | 47 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | - |
Bob E. Curry | M | 77 |
Keck Graduate Institute of Applied Life Sciences
| - |
Avery Catlin | M | 75 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | - |
Peter Salzmann | M | 56 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | - |
Sahil Chopra | M | - |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 1 Jahre |
Sean Moran | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 Jahre |
John Jenkins | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | - |
Robert Discordia | M | 60 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 Jahre |
Barbara Kosacz | F | 66 |
Keck Graduate Institute of Applied Life Sciences
| - |
Clive Dix | M | 70 |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | 7 Jahre |
Stephen Eck | M | 69 |
Keck Graduate Institute of Applied Life Sciences
| - |
Jacques Suzanne | F | 53 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Sol Barer | M | 76 | 25 Jahre | |
Robert Hugin | M | 69 | 19 Jahre | |
Josiah Hornblower | M | 48 | 5 Jahre | |
Jacqualyn Fouse | M | 62 | 7 Jahre | |
Jonathan Biller | M | 61 | 8 Jahre | |
Kevin Starr | M | 61 | 13 Jahre | |
John L. Knopf | M | 71 | 13 Jahre | |
Francois Nader | M | 67 | 7 Jahre | |
Brendan Delaney | M | 49 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | 11 Jahre |
Habib Dable | M | 54 | 5 Jahre | |
Scott Smith | M | 61 | 10 Jahre | |
Herve Hoppenot | M | 64 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | 11 Jahre |
Timothy J. Smith | M | - | - | |
Christine Bunt | F | - |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | 4 Jahre |
Adam Veness | M | 38 | 7 Jahre | |
Mark Corrigan | M | 66 |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | 4 Jahre |
Thomas Daniel | M | 69 | 10 Jahre | |
Peter Kellogg | M | 67 | 5 Jahre | |
Steven D. Ertel | M | 54 | 11 Jahre | |
Frank Morich | M | 69 | 5 Jahre | |
Thomas McCourt | M | 66 | 5 Jahre | |
Asha Nayak | M | - | 3 Jahre | |
Douglas Pagán | M | 52 | 6 Jahre | |
Christopher Rovaldi | M | 50 | 11 Jahre | |
Mike Daulton | M | - |
National Audubon Society, Inc.
National Audubon Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Audubon Society, Inc. conserves and restores natural ecosystems. The firm preserves species of birds, other animals, and their natural habitats. Its projects include saving habitat in the everglades, arctic wildlife refuge, long island sound, and mississippi river basin. The company was founded in 1905 by George Bird Grinnell and is headquartered in New York City, NY. | - |
Markus Enzelberger | M | 55 | 18 Jahre | |
Wendy Johnson | F | 72 | 7 Jahre | |
Christoph H. Westphal | M | 56 | 10 Jahre | |
Anthony Evnin | M | 83 | 10 Jahre | |
Todd James | M | - | 6 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 84 | 84,00% |
Deutschland | 11 | 11,00% |
Irland | 5 | 5,00% |
Vereinigtes Königreich | 1 | 1,00% |
Belgien | 0 | -.--% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- George Golumbeski
- Persönliches Netzwerk